Related Experiment Video
Updated: May 11, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Psychologic disorders and statin use: a propensity score-matched analysis
Ishak Mansi1, Christopher R Frei, Mary J Pugh
1Brooke Army Medical Center, San Antonio, Texas, USA. ishak.mansi@va.gov
Pharmacotherapy
|April 30, 2013
Summary
Statin therapy showed no increased risk for major psychological disorders like schizophrenia or depression in a military population. This study found similar rates of psychiatric conditions between statin users and non-users.
Area of Science:
- Cardiovascular Health
- Psychiatric Epidemiology
- Pharmacovigilance
Background:
- Statins are widely prescribed cholesterol-lowering medications.
- Potential neurological and psychiatric side effects of statins remain a subject of investigation.
- Understanding these risks is crucial for patient safety and informed treatment decisions.
Purpose of the Study:
- To investigate the association between statin use and the incidence of specific psychological disorders.
- To evaluate risks for schizophrenia, psychosis, major depression, and bipolar disorder in a military cohort.
Main Methods:
- Retrospective, observational, population-based cohort study.
- Utilized data from a military health system, including 46,249 patients aged 30-85.
- Employed propensity score matching to create comparable groups of statin users (n=6972) and non-users (n=6972).
Main Results:
- No statistically significant differences in the occurrence of schizophrenia, psychosis, major depression, or bipolar disorder were observed.
- Odds ratios for psychosis (Psych1) were 0.9 (0.75-1.05).
- Odds ratios for major depression and bipolar disorder (Psych2) were 1.02 (0.94-1.11).
- Odds ratios for all analyzed psychological disorders (Psych3) were 1.02 (0.96-1.1).
Conclusions:
- Statin therapy was not associated with an increased risk of developing major psychological disorders in this military population.
- The findings suggest similar psychological disorder incidence between statin users and non-users.
- This research contributes to the understanding of statin safety profiles regarding psychiatric health.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...